At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change with the US FDA’s acceptance of a New Drug .
At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change with the US FDA’s acceptance of a New Drug .
The U.S. Food and Drug Administration has agreed to review a new drug application for ecstasy to be developed for the treatment of post-traumatic stress disorder after studies have shown a decrease in symptoms common to PTSD among users of certain psychedelic drugs.
Breaking: The US FDA Just Granted Priority Review Of An MDMA Treatment For PTSD menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
The investigational therapy combines MDMA, a psychoactive drug, with psychological interventions that include psychotherapy, talk therapy and other supportive services.